Clinical Trials Browser

Phase 1/2 × Solid Tumor, Adult × Other solid neoplasm × Clear all

NCT06554795 2026-03-19

First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT05689853 2026-03-18

Study of AK119 Combined With AK112 in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT04219254 2026-02-25

A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT04725474 2026-01-12

GDFATHER

Phase 1/2 Active not recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT06265727 2026-01-08

A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT05307874 2025-12-24

EVICTION-2

Phase 1/2 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT06977737 2025-12-08

ATTEST

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT06088004 2025-08-22

Phase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT05435339 2025-04-22

A Study to Evaluate Safety, Tolerability, and Preliminary Effect of the GEN1053 Antibody on Malignant Solid Tumors as Monotherapy

Phase 1/2 Terminated

31 enrolled 29 charts

Other solid neoplasm

Solid Tumor, Adult

NCT06895733 2025-03-26

Study of Pazopanib Combined With Palbociclib for Refractory Solid Tumors With Co-amplified in the 11q13(FGF3/4/19/CCND1)

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT04585035 2025-03-18

Study to Evaluate D-1553 in Subjects With Solid Tumors

Phase 1/2 Active not recruiting

Other solid neoplasmThoracic

Solid Tumor, Adult

NCT04597541 2025-03-10

A Study of AK112 for Advanced Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT05559541 2025-02-19

Study of AK119 Combined With AK104 in Patients With Advanced Solid Tumors

Phase 1/2 Terminated

Other solid neoplasm

Solid Tumor, Adult

NCT06524804 2024-12-18

A Phase Ib/II Study of BY101298 , an Oral DNA-PK Inhibitor, Combined with Radiotherapy in Patients with Malignant Solid Tumors

Phase 1/2 Terminated

Other solid neoplasm

Solid Tumor, Adult

NCT04020185 2024-12-11

Safety and Efficacy Study of IMSA101 in Refractory Malignancies

Phase 1/2 Completed

40 enrolled 16 charts

Other solid neoplasm

Solid Tumor, Adult

NCT06622486 2024-11-07

First-in-human Trial of EGL-001 in Patients with Selected Advanced And/or Metastatic Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT04121442 2024-08-06

Isunakinra Alone and in Combination With a PD-1/PD-L1 Inhibitor in Patients With Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT04092673 2024-05-21

Zotatifin

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT06144671 2023-12-20

GT201 Injection For The Treatment Of Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT06056323 2023-10-23

A Study of HB0045 Injection in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT03160833 2020-02-13

A Study of HMPL-453 in Patients With Advanced Solid Malignancies

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT03030001 2017-01-24

PD-1 Antibody Expressing CAR T Cells for Mesothelin Positive Advanced Malignancies

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor, Adult